Role of health technology assessment in pharmaceutical market access in developed countries
Kahveci, Rabia and Oortwijn, Wija and Godman, Brian and Meltem Koç, E. and Tibet, Birol; Wertheimer, Albert I. and Kockaya, Guvenc, eds. (2018) Role of health technology assessment in pharmaceutical market access in developed countries. In: Pharmaceutical Market Access in Developed Markets. SEEd Medical Publishers, Italy, pp. 225-256. ISBN 8897419739
Preview |
Text.
Filename: Kahveci_etal_SEEd_2017_Role_of_health_technology_assessment_in_pharmaceutical.pdf
Final Published Version Download (780kB)| Preview |
Abstract
Introduction and use of a health technology in a health care setting has clinical, economic, as well as organizational, social-cultural, legal and ethical impacts. Health Technology Assessment (HTA) is a multidisciplinary field that addresses these impacts, considering healthcare context as well as available alternatives. HTA mainly aims to inform policy and clinical decision making. While systematically evaluating the effects of the health technology, HTA addresses direct and intended effects as well as the indirect and unintended effects. It is a multidisciplinary field with well-developed systematic processes and methods
-
-
Item type: Book Section ID code: 61921 Dates: DateEvent31 March 2018Published2 October 2017AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 03 Oct 2017 15:40 Last modified: 11 Nov 2024 15:11 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/61921